Impairment of PKA function in platinum-resistant cells results in inhibition of CREB1 phosphorylation at Ser-133, which in turn decreases the survival of platinum-resistant cancer cells and inhibits the G2-M cell cycle. Here, CREB1 is linked to cancer.